PubRank

French Observatory on the Management of Cardiogenic Shock in 2016 (FRENSHOCK)

Clinical Trial ID NCT02703038

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02703038

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012 16.00
2 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014 9.73
3 Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012 9.22
4 Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010 8.58
5 Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999 6.93
6 Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013 4.39
7 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013 3.86
8 Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007 2.90
9 Cardiogenic shock: current concepts and improving outcomes. Circulation 2008 2.60
10 A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J 2010 1.46
11 Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003 1.41
12 Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 2008 1.36
13 Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999 1.36
14 Management of cardiogenic shock. Eur Heart J 2015 1.20
15 Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 2010 1.17
16 Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 2003 1.14
17 Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J 2012 0.94
18 Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 2009 0.89
Next 100